Yahoo
NasdaqGS - Delayed Quote USD

Ascendis Pharma A/S (ASND)

270.56 -0.56 (-0.21%)
At close: September 4 at 4:00:00 PM EDT
271.00 +0.44 (+0.16%)
After hours: September 4 at 7:39:57 PM EDT
Trade ASND on Coinbase
View in AlphaSpace Currency in EUR All numbers in thousands
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
1,047,020
720,132
363,641
266,718
51,174
Cost of Revenue
91,125
94,915
44,258
44,395
12,137
Gross Profit
955,895
625,217
319,383
222,323
39,037
Operating Expense
693,179
761,488
598,146
677,864
600,851
Operating Income
262,716
-136,271
-278,763
-455,541
-561,814
Net Non Operating Interest Income Expense
-29,098
-44,877
-39,895
-12,554
-23,256
Other Income Expense
-135,779
-31,503
-54,583
-6,049
7,253
Pretax Income
97,839
-212,651
-373,241
-474,144
-577,817
Tax Provision
-643,919
15,383
4,843
7,303
5,377
Net Income Common Stockholders
741,758
-228,034
-378,084
-481,447
-583,194
Diluted NI Available to Com Stockholders
741,758
-228,034
-378,084
-481,447
-583,194
Basic EPS
8.02
-3.76
-6.53
-8.55
-10.40
Diluted EPS
7.57
-3.76
-6.53
-8.55
-10.40
Basic Average Shares
61,022.97
60,647.34
57,891.57
56,287.06
56,071.79
Diluted Average Shares
61,732.98
60,647.34
57,891.57
56,287.06
56,071.79
Total Operating Income as Reported
266,170
-136,271
-278,763
-455,541
-561,814
Total Expenses
784,304
856,403
642,404
722,259
612,988
Net Income from Continuing & Discontinued Operation
741,758
-228,034
-378,084
-481,447
-583,194
Normalized Income
815,672
-190,263.31
-350,810.83
-491,200.34
-602,904.50
Interest Income
17,045
15,301
14,361
16,857
7,426
Interest Expense
75,184
80,647
65,504
44,065
30,682
Net Interest Income
-29,098
-44,877
-39,895
-12,554
-23,256
EBIT
173,023
-132,004
-307,737
-430,079
-547,135
EBITDA
190,655
-114,308
-290,023
-411,168
-529,177
Reconciled Cost of Revenue
82,598
87,042
33,606
44,395
12,137
Reconciled Depreciation
17,632
17,696
17,714
18,911
17,958
Net Income from Continuing Operation Net Minority Interest
741,758
-228,034
-378,084
-481,447
-583,194
Total Unusual Items Excluding Goodwill
-123,190
-47,811
-34,523
12,346
24,950
Total Unusual Items
-123,190
-47,811
-34,523
12,346
24,950
Normalized EBITDA
313,845
-66,497
-255,500
-423,514
-554,127
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-49,276
-10,040.31
-7,249.83
2,592.66
5,239.50
12/31/2022 - 1/28/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: